Comparing Etodolac vs Mobic
Etodolac | Mobic (meloxicam) |
|
---|
Etodolac | Mobic (meloxicam) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Etodolac is an NSAID that may be used for the treatment of pain or pain associated with osteoarthritis or rheumatoid arthritis. It is associated with an increased risk of cardiovascular and... View more |
Prescription only
Prescribed for Osteoarthritis, Juvenile Rheumatoid Arthritis, Rheumatoid Arthritis. Mobic may also be used for purposes not listed in this medication guide. |
Related suggestions Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Popular comparisons
|
|||||||
More about Etodolac | More about Mobic (meloxicam) | ||||||||
Ratings & Reviews | |||||||||
Etodolac has an average rating of 7.5 out of 10 from a total of 82 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 18% reported a negative effect. |
Mobic has an average rating of 7.4 out of 10 from a total of 131 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Etodolac side effects |
View all Mobic side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
Lower cost generic approved | ||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Etodolac prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
N/A |
Other meloxicam brands include: Qamzova, Xifyrm | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
6.7 hours |
20 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 388 drugs are known to interact with Etodolac:
|
A total of 473 drugs are known to interact with Mobic:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
January 31, 1991 |
April 13, 2000 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Cymbalta
Cymbalta (duloxetine) is used to treat major depressive disorder, general anxiety disorder and ...
Celecoxib
Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain or inflammation ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Methylprednisolone
Methylprednisolone is used to treat conditions such as allergies, arthritis, lupus and ulcerative ...
Naproxen
Naproxen is a nonsteroidal anti-inflammatory drug used to treat pain or inflammation caused by ...
Diclofenac
Diclofenac is a nonsteroidal anti-inflammatory drug used to treat pain and inflammation associated ...
Duloxetine
Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor antidepressant used to ...
Meloxicam
Meloxicam is a nonsteroidal anti-inflammatory drug used to treat pain or inflammation caused by ...
Aspirin
Aspirin is used to treat mild to moderate pain and to reduce fever or inflammation. Learn about ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.